Stockreport

Brickell Biotech to Report Fourth Quarter and Full Year 2019 Financial Results on March 18, 2020

Brickell Biotech, Inc.  (BBI) 
PDF BOULDER, Colo., March 09, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing inn [Read more]